Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatially constrained gene regulation identifies key genetic contributions of preeclampsia, hypertension, and proteinuria†. | Biol Reprod | 2023 | 36738257 | PubTator, text mining | PubMed |
| Establishment and evaluation of nomogram for predicting intraventricular hemorrhage in neonatal acute respiratory distress syndrome. | BMC Pediatr | 2023 | 36707776 | PubTator, text mining | PubMed |
Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS. | J Assist Reprod Genet | 2023 | 36695944 | PubTator, text mining | PubMed |
| Total Hip Arthroplasty in the Setting of Post-Traumatic Arthritis Following Acetabular Fracture: A Systematic Review. | Arthroplast Today | 2023 | 36691464 | PubTator, text mining | PubMed |
| Ethanol-induced ceramide production causes neuronal apoptosis by increasing MCL-1S-mediated ER-mitochondria contacts. | Neurobiol Dis | 2023 | 36689912 | PubTator, text mining | PubMed |
| RNA therapeutics in the clinic. | Bioeng Transl Med | 2023 | 36684099 | PubTator, text mining | PubMed |
| Sortilin and hypertension. | Curr Opin Nephrol Hypertens | 2023 | 36683537 | PubTator, text mining | PubMed |
| Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1. | Biochem Biophys Res Commun | 2023 | 36682331 | PubTator, text mining | PubMed |
| Molecular Mechanisms, Genotype-Phenotype Correlations and Patient-Specific Treatments in Inherited Metabolic Diseases. | J Pers Med | 2023 | 36675778 | PubTator, text mining | PubMed |
| Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases. | Int J Mol Sci | 2023 | 36674974 | PubTator, text mining | PubMed |
| Structural Insights Uncover the Specific Phosphoinositide Recognition by the PH1 Domain of Arap3. | Int J Mol Sci | 2023 | 36674645 | PubTator, text mining | PubMed |
| Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity. | Biomolecules | 2023 | 36671568 | PubTator, text mining | PubMed |
| The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers. | Biomolecules | 2023 | 36671552 | PubTator, text mining | PubMed |
| Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate. | Antioxidants (Basel) | 2023 | 36671005 | PubTator, text mining | PubMed |
| The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis. | Reprod Sci | 2023 | 36662421 | PubTator, text mining | PubMed |
| Genetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management. | Int J Nephrol Renovasc Dis | 2023 | 36636322 | PubTator, text mining | PubMed |
| The chromatin determinants and Ph1 gene effect at wheat sites with contrasting recombination frequency. | J Adv Res | 2023 | 36632886 | PubTator, text mining | PubMed |
| Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment. | Nutrients | 2023 | 36615886 | PubTator, text mining | PubMed |
| Nanomedicine for renal cell carcinoma: imaging, treatment and beyond. | J Nanobiotechnology | 2023 | 36597108 | PubTator, text mining | PubMed |
| Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease. | Int J Biol Sci | 2023 | 36594091 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=27